Tax Consequences Clause Example from Business Contracts
This example Tax Consequences clause appears in 60 contracts from 55 companies
Turning Point Therapeutics, Inc. 2013 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on March 21, 2019)
Cirius Therapeutics, Inc. 2017 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on January 11, 2019)
2012 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on April 15, 2019)
Forms of grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 21, 2019)
Amended and Restated 2005 Stock Option/Stock Issuance Plan and Form of Stock Option Grant Notice, Option Agreement and Form of Notice of Exercise (Filed With SEC on July 17, 2019)
2015 Stock Option/Stock Issuance Plan and Form of Stock Option Grant Notice, Option Agreement, Form of Notice of Exercise, Form of Restricted Stock Unit Award Grant Notice and... (Filed With SEC on July 17, 2019)
Progyny, Inc. 2017 Equity Incentive Plan, as amended, and forms of agreements thereunder (Filed With SEC on September 27, 2019)
Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2017 Equity Incentive Plan (Filed With SEC on January 3, 2020)
2017 Equity Incentive Plan, as amended, and related form agreements (Filed With SEC on June 21, 2019)
2015 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on May 11, 2020)
Outset Medical, Inc. 2019 Equity Incentive Plan and related form agreements (Filed With SEC on August 21, 2020)
Metacrine, Inc. Amended and Restated 2015 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on August 24, 2020)
2020 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (Filed With SEC on September 2, 2020)
Form of Stock Option Grant Notice and Option Agreement for the 2016 Equity Incentive Plan, as amended (Filed With SEC on September 11, 2020)
Form of Stock Option Grant Notice and Option Agreement for the 2016 Equity Incentive Plan, as amended (Filed With SEC on September 11, 2020)
Form of Option Agreement under the 2016 Equity Incentive Plan (Filed With SEC on October 9, 2020)
Form of Stock Option Grant Notice and Option Agreement under 2018 Equity Incentive Plan (Filed With SEC on October 16, 2020)
Forms of Option Grant Notice and Option Agreement under 2019 Equity Incentive Plan (Filed With SEC on November 12, 2020)
Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the Lucira Health, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on January 15, 2021)
Decipher Biosciences, Inc. 2018 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on January 19, 2021)
Talis Biomedical Corporation 2013 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on January 22, 2021)
Form of Stock Option Agreement under 2016 Equity Incentive Plan (Filed With SEC on February 4, 2021)
Form of Stock Option Agreement under the 2017 Equity Incentive Plan, as amended (Filed With SEC on February 8, 2021)
Form of Stock Option Agreement under the 2018 Equity Incentive Plan, as amended (Filed With SEC on February 8, 2021)
Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2016 Equity Incentive Plan (Filed With SEC on February 10, 2021)
Forms of grant notice, stock option agreement and notice of exercise under the Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on February 19, 2021)
Forms of Notice of Grant, Stock Option Agreement, Notice of Exercise and Notice of Early Exercise under Legacy AppHarvest 2018 Equity Incentive Plan (Filed With SEC on March 2, 2021)
Design Therapeutics, Inc. 2018 Equity Incentive Plan, as amended, and Forms of Option Grant Notice, Option Agreement, Notice of Exercise, Early Exercise Stock Purchase Agreement,... (Filed With SEC on March 5, 2021)
Forms of Stock Option Grant Notice, Option Agreement and Exercise Notice under the 2020 Equity Incentive Plan (Filed With SEC on March 9, 2021)
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on March 19, 2021)
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2017 Equity Incentive Plan (Filed With SEC on April 23, 2021)
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on May 10, 2021)
Form of Stock Option Grant Notice and Agreement under 2016 Equity Incentive Plan (Filed With SEC on May 5, 2021)
Form of Option Agreement (Incentive Stock Option or Non-statutory Stock Option) under the SomaLogic, Inc. 2017 Equity Incentive Plan (Filed With SEC on May 14, 2021)
Forms of grant notice, stock option agreement, and notice of exercise under the Xometry, Inc. 2016 Equity Incentive Plan (Filed With SEC on June 4, 2021)
Vividion Therapeutics, Inc. 2016 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on June 25, 2021)
Forms of Option Agreement, Notice of Stock Option Grant and Exercise Notice under Cytek Biosciences, Inc. 2015 Equity Incentive Plan (Filed With SEC on July 2, 2021)
Surrozen, Inc. 2021 Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on August 17, 2021)
Form of Stock Option Grant Notice and Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on October 4, 2021)
Sweetgreen, Inc. 2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on October 25, 2021)
2020 Equity Incentive Plan and form of award agreement thereunder (Filed With SEC on November 19, 2021)
2019 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (as amended) (Filed With SEC on January 4, 2022)
Intrinsic Medicine, Inc. 2021 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement, Notice of Exercise and Early Exercise Agreement, thereunder (Filed With SEC on April 8, 2022)
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Genelux Corporation 2019 Equity Incentive Plan (Filed With SEC on June 24, 2022)
Form of Stock Option Grant Notice and Option Agreement under 2018 Equity Incentive Plan (Filed With SEC on September 21, 2022)
2022 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award... (Filed With SEC on November 3, 2022)
Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan (Prior Plan) and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise and Early... (Filed With SEC on September 14, 2018)
Adaptive Insights, Inc. 2013 Equity Incentive Plan, as amended, and forms of agreements thereunder (Filed With SEC on May 17, 2018)
2013 Equity Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on June 25, 2018)
Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the 2015 Equity Incentive Plan (Filed With SEC on June 18, 2018)
Amended and Restated 2016 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on June 8, 2018)
Amended and Restated 2016 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on May 25, 2018)
SENESTECH, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: July3, 2015 APPROVED BY THE STOCKHOLDERS: July ___,2015 TERMINATION DATE: July 3, 2025 (Filed With SEC on September 21, 2016)
KURA ONCOLOGY, INC. AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN AMENDED AND RESTATED BY THE BOARD:MARCH 6, 2015 APPROVED BY THE STOCKHOLDERS:MARCH 6, 2015 (Filed With SEC on March 12, 2015)
PROTEINSIMPLE STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on May 1, 2014)
LUMENA PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JUNE 15, 2012 APPROVED BY THE STOCKHOLDERS:JUNE 15, 2012 AMENDED BY THE BOARD... (Filed With SEC on April 2, 2014)
Form of Option Grant SEER 2013 Equity Incentive Plan (Filed With SEC on March 27, 2014)
Form of Incentive Stock Option or Nonstatutory Stock Option Agreement under 2012 Equity Incentive Plan (Filed With SEC on October 18, 2017)
DOVA PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on June 2, 2017)
CELLADON CORPORATION 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 26, 2012 APPROVED BY THE SHAREHOLDERS:JANUARY 26, 2012 AMENDED BY THE BOARDOF DIRECTORS:... (Filed With SEC on October 29, 2013)
CELLADON CORPORATION 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 26, 2012 APPROVED BY THE SHAREHOLDERS:JANUARY 26, 2012 AMENDED BY THE BOARDOF DIRECTORS:... (Filed With SEC on October 11, 2013)
